Stock Market Close Highlights: Sensex sheds 330 pts, Nifty ends at 23,092; Smallcap shares bleed
Stock Market Highlights: Small-cap shares felt the most heat among the broader markets, with Nifty Smallcap100 ending lower by 2.35 per cent dragged by Cyient, and Jupiter Wagons
 "Benchmark indices dropped as much as 2 per cent before recouping half the losses, as uncertainty around the tightly contested US Presidential election, sustained selling by foreign portfolio investors (FPIs), and earnings disappointments weighed on t")
Stock Market Highlights Friday, January 24, 2025: Benchmark equity indices, BSE Sensex and NSE Nifty50, ended the week's last trading session on a lower note. The 30-share Sensex shed as much as 329.92 points or 0.43 per cent to settle at 76,190.46. The index traded in the range of 76,985.95-76,091.75 today.
Mirroring the Sensex, NSE Nifty50 also ended lower by 113.15 points or 0.49 per cent at 23,092.20. The Nifty50 recorded a day's high of 23,347.30, while the day's low was 23,050.
The day ended in favor of the bears as 31 out of the 50 constituent stocks of Nifty50 ended in the red, dragged by Trent, Dr Reddy's Labs, BPCL, Adani Enterprises, and Mahindra & Mahindra, with losses extending up to 4.90 per cent. Meanwhile, Hindustan Unilever, Britannia Industries, Eicher Motors, Grasim Industries, and ICICI Bank were among the 19 constituent stocks that ended in the green, with gains extending up to 2.52 per cent.
Small-cap shares felt the most heat among the broader markets, with Nifty Smallcap100 ending lower by 2.35 per cent dragged by Cyient, and Jupiter Wagons who ended lower by upto 22.80 per cent. Meanwhile, the Nifty Midcap100 index ended lower by 1.55 per cent.
All sectoral indices, barring Nifty FMCG and IT, ended in the red. Among others, Nifty Realty, Pharma, Healthcare, and OMCs indices ended lower by over 2 per cent each. Meanwhile, Nifty Auto, PSU Bank, and Consumer Durables indices ended lower by over 1 per cent each.
3:59 PM
Stock Market LIVE Updates: Market expert view
Stock Market LIVE Updates: The market is haywire, with sentiment so weak that even results in-line with expectations are triggering selloffs. While the broader market is under pressure, positively, large-cap stocks are showing some resilience. From the taper-tantrum to geopolitical risks, the Indian market has borne numerous challenges in its history. Similarly, the ongoing appreciation of the USD could reverse once market yields flatten out, as the Trump administration is to sustain is slowing. This negative market bias is not expected to persist for long. For long-term investors, this is not the time to sell but rather be patient and adopt an accumulation strategy.
View by Vinod Nair, Head of Research, Geojit Financial Services.
View by Vinod Nair, Head of Research, Geojit Financial Services.
3:58 PM
Stock Market LIVE Updates: Technical view
Stock Market LIVE Updates: Nifty witnessed a volatile day of trade today. It witnessed selling pressure emerge from the upper end of the broad range 23350 – 23400 and slipped to close in the negative down 113 points. Since the past four trading sessions the Nifty is trading in the broad range of 23,000 – 23,400. Divergence among the daily and hourly time frame momentum indicator can lead to further consolidation. Bollinger bands are contracting also suggesting a rangebound movement.
Thus until, the Nifty does not breach the support zone of 23,050 – 23000 we can expect the rangebound price action to continue. Stock specific weakness in the broader market is visible as the small cap index and midcap index w,ere down 2.35 per cent and 1.55 per cent respectively. On the Nifty a breach below 23,000 could lead to a fall towards 22,670 which coincides with the 38.2 per cent Fibonacci retracement level of the rise form 16,828 – 26,277.
Thus until, the Nifty does not breach the support zone of 23,050 – 23000 we can expect the rangebound price action to continue. Stock specific weakness in the broader market is visible as the small cap index and midcap index w,ere down 2.35 per cent and 1.55 per cent respectively. On the Nifty a breach below 23,000 could lead to a fall towards 22,670 which coincides with the 38.2 per cent Fibonacci retracement level of the rise form 16,828 – 26,277.
View by Jatin Gedia – Technical Research Analyst at Mirae Asset Sharekhan.
3:43 PM
Stock Market LIVE Updates: Here's a look at Nifty gainers and loser at close
Stock Market LIVE Updates: Dr Reddy's Laboratories, Apollo Hospitals, Cipla were among the top losers on Nifty50.
3:40 PM
Stock Market LIVE Updates: Here's a look at Sensex gainers and loser at close
Stock Market LIVE Updates: M&M, Tata Motors, Zomato were among the top losers on Sensex at close.
3:39 PM
Stock Market LIVE Updates: A glance at broader market
Stock Market LIVE Updates: Broader market indices in red at close.
3:35 PM
Stock Market LIVE Updates: Nifty settles 113.15 pts lower at 23,092.20
Stock Market LIVE Updates: NSE Nifty finished 113.15 points or 0.49 per cent lower at 23,092.20.
3:33 PM
Stock Market LIVE Updates: Sensex closes 329.92 pts lower at 76,190.46
Stock Market LIVE Updates: BSE Sensex closed 329.92 points or 0.43 per cent lower at 76,190.46.
3:26 PM
Stock Market LIVE Updates: Tata Electronics buys 60% stake in Pegatron's India arm for iPhone plant
Stock Market LIVE Updates: The electronics manufacturing business from Tata Group, Tata Electronics today announced the acquisition of a controlling 60 per cent stake in Pegatron Technology India Private Limited (PTI). The financial details of the deal were not available, but this will allow the company to expand its local iPhone manufacturing. Read more
3:20 PM
Stock Market LIVE Updates: Sobha hits 52-week low; stock tanks 27% thus far in January
Stock Market LIVE Updates: Shares of Sobha hit a 52-week low of Rs 1,148.30, as they declined 6 per cent on the BSE in Friday’s intra-day trade on growth concerns. The stock price of this real estate company fell below its previous low of Rs 1,176.01 touched on March 18, 2024. Read more
3:06 PM
Stock Market LIVE Updates: Lupin receives USFDA approval to market its generic HIV medications
Drug firm Lupin on Friday said it has received approval from the US health regulator to market a generic HIV medication in the US market.
The company has received tentative approval from the US Food and Drug Administration (USFDA) under the US President's Emergency Plan for AIDS Relief (PEPFAR) for Abacavir, Dolutegravir and Lamivudine tablets, the Mumbai-base drug maker said in a statement. Read more
Topics : MARKETS WRAP MARKET WRAP MARKET LIVE stock market trading Indian stock market BSE Sensex Nifty50 Indian equities FIIs DIIs Donald Trump Rate cuts US Federal Reserve IPO market SME IPOs IPOs initial public offerings
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Jan 24 2025 | 7:28 AM IST